Dynatrace Holdings LLC

Dick's Sporting Goods shares plunged more than 27% after the retailer reported revenue of $5.59 billion, below the $5.65 billion expected by analysts polled by LSEG, citing a challenging footwear market. Dynatrace rose 3% after Morgan Stanley upgraded it to overweight, while Shift4 Payments gained nearly 4% on a Wells Fargo upgrade to overweight. Moderna rallied 13% after Wolfe Research upgraded it to peer perform, and Marvell Technology jumped 5% after Susquehanna and Rosenblatt raised price targets. Advanced Micro Devices gained 5% after Raymond James upgraded it to strong buy with a $641 price target, and Kura Oncology climbed almost 10% after its CEO disclosed buying 100,000 shares. Navitas Semiconductor rose 5% after announcing a $232.8 million deal to acquire Claros.

Dynatrace has signed a definitive agreement to acquire AI observability leader Arize in a cash and stock transaction valued at $915 million. The deal consists of approximately $815 million in cash plus replacement equity awards for Arize employees joining Dynatrace, and is expected to close later this quarter or early in Dynatrace's third quarter, subject to regulatory reviews. Dynatrace expects the transaction to be approximately 200 basis points accretive to ARR growth and 175 basis points dilutive to non-GAAP operating margin for fiscal 2027, with incremental operating margin expansion expected into fiscal 2028 and beyond. Arize's two founders, Jason Lopatecki and Aparna Dhinakaran, will join Dynatrace at closing, with Lopatecki continuing to lead the Arize team and reporting directly to CEO Rick McConnell. The acquisition aims to provide end-to-end AI observability from development to production, combining Arize's developer-focused evaluation tools with Dynatrace's enterprise observability platform.

Dynatrace reported first-quarter fiscal 2027 results that exceeded guidance, with total ARR reaching $2.14 billion, up 17% year-over-year on a constant currency basis. Net new ARR was $85 million, growing 66% overall and 41% organically, driven by record new logo ARR growth of more than 160% and an average land size of nearly $285,000. Total revenue was $555 million, and subscription revenue was $530 million, both up 15% year-over-year on a constant currency basis. Non-GAAP operating margin was 29%, and non-GAAP net income was $0.48 per diluted share, $0.03 above the high end of guidance. The company highlighted that log management consumption reached nearly $200 million in annualized consumption, nearly doubling in the last two quarters, and that AI observability adoption grew to 1,000 customers, up from roughly 850 last quarter. For fiscal 2027, Dynatrace maintained its constant currency ARR growth guidance of 15.5% to 16.5% and raised its full-year non-GAAP operating margin guidance to a range of 29.5% to 29.75%. CFO Jim Benson announced his intention to retire by the end of the fiscal year on March 31, 2027.

Dynatrace has appointed Chandu Thota, a senior engineering executive from Google, to its Board of Directors. The company also announced new autonomous agents, a no-code agent builder, and additional integrations within its Dynatrace Intelligence platform, alongside a native resilience testing app from Gremlin Inc. that now runs directly inside the platform. These moves signal a stronger focus on automation and reliability across complex cloud environments as Dynatrace positions its platform as a core tool for digital operations teams.

StockStory identified Dynatrace as a resilient software stock with promising prospects, while advising caution on Domo and Asure Software. Dynatrace, with an $11.77 billion market cap, benefits from 24% average billings growth, an 81.7% gross margin, and a 26.2% free cash flow margin. Domo faces underwhelming 1.3% billings growth and a projected 1.7% sales decline, trading at 0.5 times forward price-to-sales. Asure Software's 12.3% annual growth lagged peers, with estimated growth slowing to 10.4% and a weak 5.3% free cash flow margin, trading at 1.4 times forward price-to-sales.

Dynatrace reported Q1 billings of $849.1 million, with year-on-year growth averaging 24% over the last four quarters, signaling robust customer demand. The company maintained an 81.7% gross margin over the past year, though margins have declined 0.8 percentage points over two years. GAAP operating margin rose 1.6 percentage points over two years to 12.2% for the trailing 12 months. Shares trade at $45.15, or 5.8 times forward price-to-sales.

Dynatrace announced its intent to pursue FedRAMP High authorization and expanded government security standards, building on its existing FedRAMP Moderate authorization achieved in 2020. The company is engaging with customers and partners to align future platform capabilities with FedRAMP High, Department of Defense, and other evolving government security requirements. Dynatrace's unified observability platform and Grail data lakehouse architecture are designed to support highly regulated environments, with a roadmap to meet higher security baselines. The effort is part of a broader public sector strategy to support U.S. federal agencies, defense and intelligence organizations, and global public sector customers requiring elevated security and compliance.

William Blair updated its July Analyst Conviction List, adding Oracle, American Express, Ecolab, Comfort Systems USA, Boot Barn, LifeStance Health, Genmab, Silence Therapeutics, Tyra Biosciences, Arxis, Novanta, Dynatrace, Everpure, and ServiceTitan. The firm said Oracle is emerging as a major beneficiary of the AI infrastructure buildout, with hyperscale cloud commitments driving record remaining performance obligations and stronger revenue visibility. Removed stocks included Meta Platforms, Chewy, SharkNinja, Chime, Flywire, LPL Financial, Palomar, Exponent, GFL Environmental, Encompass Health, Waystar, Insmed, LENZ Therapeutics, Ocular Therapeutix, Curtiss-Wright, Mayville Engineering, Standex, Arista Networks, Guidewire, JLL, Procore, and Rubrik, all through automatic six-month removals. Axsome Therapeutics was removed after FDA approval for Auvelity in Alzheimer’s disease agitation and a roughly 48% gain since its April addition, while Rollins was removed as near-term growth and margin trends looked less clear.

Goldman Sachs raised its price target on Dynatrace to $50 from $45 while maintaining a Buy rating. Analyst Matthew Martino cited increased confidence in the company's fiscal 2027 outlook after management addressed concerns about slower fourth-quarter net new annual recurring revenue growth and ambitious guidance. Management attributed recent softness mainly to Europe and outlined drivers for reaccelerating growth with potential upside later in the year. Separately, BMO Capital also lifted its price target on Dynatrace to $50 from $43 with an Outperform rating, noting a credible bridge to fiscal 2027 annualized recurring revenue targets.

StockStory identified Dynatrace as a cash-producing stock worth investigating, citing its 26.2% trailing 12-month free cash flow margin, 24% billings growth, and 81.7% gross margin. The firm also flagged FactSet and Lemonade as stocks to ignore, pointing to FactSet's 5.6% annual sales growth and 7.1% annual EPS growth, and Lemonade's 2.3% free cash flow margin, 18.4% annual book value per share decline, and negative return on equity.

Datadog reported first-quarter revenues of $1.01 billion, up 32.2% year on year and beating analyst estimates by 4.9%, making it the top performer in a group of four cloud monitoring stocks that collectively exceeded revenue consensus by 2.7%. The company added 240 enterprise customers paying more than $100,000 annually to reach a total of 4,550, and its stock has risen 58% since the report. Among peers, Dynatrace posted revenues of $531.7 million, up 19.4% and 2.1% above estimates, while Nutanix grew 10% to $703.1 million, exceeding expectations by 2.4% but delivering the weakest guidance update. PagerDuty reported flat revenues of $121 million, topping estimates by 1.2% but missing significantly on next-quarter EPS guidance and recording the slowest growth and weakest full-year outlook in the group.

Dynatrace has received fresh analyst upgrades as firms highlight its expanding role in AI-driven observability and log management amid increasingly complex enterprise AI workloads. The company's own State of Log Management 2026 report underscores how AI workloads are stressing traditional tools, reinforcing the unified platform approach analysts now emphasize. Dynatrace's narrative projects $3.0 billion in revenue and $456.3 million in earnings by 2029, with a fair value estimate of $43.85 per share, representing a 6% upside. However, some analysts remain cautious, modeling revenue of about $2.8 billion and earnings near $269 million by 2029, citing risks of slower enterprise adoption. The next earnings reports are seen as key near-term catalysts for assessing both opportunity and execution risk.